Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
21-hydroxylase (21-OH) deficiency accounts for the vast majority of nonclassic (NC) forms of congenital adrenal hyperplasia (CAH), and is associated with symptoms detectable either in childhood (precocious puberty) or sometimes only later in adulthood (hirsutism, acne, amenorrhea). While the severe forms of the disease responsible for salt wasting or simple virilization have been extensively studied, the NC 21-OH deficiency is less well characterized, especially in adults. We studied the 21-OH gene (CYP21) in a population of 69 unrelated hyperandrogenic subjects suspected to be homozygous or heterozygous for NC 21-OH deficiency, based on basal and adrenocorticotrophin (ACTH)-stimulated plasma 17-hydroxyprogesterone (17-OHP, 17-OHPSI) and 21-desoxycortisol (21-DOF, 21-DOFSI) levels. To identify all mutations involved, determination of the whole gene sequence, including exons, exon-intron junctions, and promoter region, was performed, followed by a study of large rearrangements and identification of compound heterozygotes. Alterations were identified in at least one allele of 55 hyperandrogenic subjects. Two NC alterations, Val282Leu and Pro454Ser, were detected in 68% and 7% of the affected alleles, respectively, whereas mutations involved in severe forms were identified in 21% of them. These results document the utility of a molecular diagnosis in hyperandrogenic women suspected of being either heterozygous or homozygous for NC 21-OH deficiency and clearly indicate the importance of genetic counseling in such a population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A point mutation in exon 7 (p.Val281Leu) that preserves 20% to 50% of enzyme function (38) accounts for most NCCAH alleles (31,39,40).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [39]
Citations
Cites
Structure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569
Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555 · cited 1×
“These alterations affect the secondary structure of the 21-OH enzyme, which presents a residual activity of 20% to 60% in vitro (Tusie-Luna et al. 1990, 1991; Helmberg et al. 1992; Owerbach et al. 1992; Nikoshkov et al. 1997).”
BackgroundHigh frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Steroid 21-hydroxylase deficiency: genotype may not predict phenotype
Wilson, R. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.8.2322 · Cited by 324
Tusie-Luna, M. T., Traktman, P., & White, P. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45304-x · Cited by 254
Speiser, P. W., New, M. I., & White, P. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190104 · Cited by 205
Tusie-Luna, M.-T., Speiser, P. W., Dumic, M., New, M. I., & White, P. C. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-5-685 · Cited by 183 · cited 1×
“These alterations affect the secondary structure of the 21-OH enzyme, which presents a residual activity of 20% to 60% in vitro ( Tusie-Luna et al. 1990, 1991; Helmberg et al. 1992; Owerbach et al. 1992; Nikoshkov et al. 1997).”
Background(1991) · Europe PMC (PubMed Central) · Cited by 164
Wedell, A., Ritzén, E. M., Haglund-Stengler, B., & Luthman, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7232 · Cited by 150 · cited 3×
“... 15 s 273 caggccagccgctcagcc gggaaggagccttttgcttg Exon 8 59 30 s 251 ctgctggggcaggactcca cgggctttcctcactcatcc Exon 9 59 30 s 178 aggtcctggccagcctctaa caccacattttcacggcagg Exon 10 60 30 s 389 tgccgtgaaaatgtggtgga gcaataaaggagaaactgaggt a From Wedell et al. (1992) b From Day et al. (1995) c Sequence determination of…”
BackgroundMethodInfluential
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
“Nevertheless, it appears that at least 50% of women clinically ascertained to have nonclassic CAH are compound heterozygotes for a classic and a nonclassic mutation (209, 210, 334).”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Kuismanen, S. A., Holmberg, M. T., Salovaara, R., de la Chapelle, A., & Peltomäki, P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65048-1 · Cited by 288
Bohring, A., Stamm, T., Spaich, C., Haase, C., Spree, K., Hehr, U., Hoffmann, M., Ledig, S., Sel, S., Wieacker, P., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.06.001 · Cited by 232
DNA mismatch repair and cancer
Peltomäki, P. (2001) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00058-2 · Cited by 223
Bataille, V., Snieder, H., MacGregor, A. J., Sasieni, P., & Spector, T. D. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19621.x · Cited by 220
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Tardy, V., Billaud, L., Laborde, K., Coussieu, C., Morel, Y., Vaury, C., Golmard, J.-L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1582 · Cited by 213
Self-citationDeneux, C., Tardy, V., Dib, A., Mornet, E., Billaud, L., Charron, D., Morel, Y., & Kuttenn, F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.207 · Cited by 144
Nonclassic Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/625105 · Cited by 101
Genetic approaches to stature, pubertal timing, and other complex traits
Palmert, M. R., & Hirschhorn, J. N. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00107-0 · Cited by 135
Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer
Lindgren, G., Liljegren, A., Jaramillo, E., Rubio, C., & Lindblom, A. (2002) · Gut · doi:10.1136/gut.50.2.228 · Cited by 121
Chaudhary, H., Patel, J. K., Jain, N. K., & Joshi, R. G. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00879-w · Cited by 121
CONGENITAL ADRENAL HYPERPLASIA OWING TO 21-HYDROXYLASE DEFICIENCY
Speiser, P. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70018-5 · Cited by 109
de Berker, D. A. R., Messenger, A. G., & Sinclair, R. D. (2004) · Wiley eBooks · doi:10.1002/9780470750520.ch63 · Cited by 99
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
Pignatelli, D., Carvalho, B. L., Palmeiro, A., Barros, A., Guerreiro, S. G., & Macut, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00432 · Cited by 95
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
Trapp, C. M., & Oberfield, S. E. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.009 · Cited by 81
Escobar-Morreale, H. F., Millán, J. L. S., Smith, R. R., Sancho, J., & Witchel, S. F. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00317-9 · Cited by 89
Messenger, A. G., BERKER, D. A. R., & Sinclair, R. D. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch66 · Cited by 63
Puberty and polycystic ovary syndrome
Witchel, S. F. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.028 · Cited by 68
Candidate gene analysis in premature pubarche and adolescent hyperandrogenism
Witchel, S. F., Smith, R. L., Tomboc, M., & Aston, C. E. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01798-2 · Cited by 67
Glintborg, D., Hermann, A. P., Brusgaard, K., Hangaard, J., Hagen, C., & Andersen, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1214 · Cited by 55
Hyperandrogenism in carriers of CYP21 mutations: the role of genotype
Admoni, O., Israel, S., Lavi, I., Gur, M., & Tenenbaum‐Rakover, Y. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02521.x · Cited by 58
Novel Mutations in CYP21 Detected in Individuals with Hyperandrogenism
Lajic, S. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2824 · Cited by 51
Self-citationWitchel, S. F., Kahsar-Miller, M., Aston, C. E., White, C., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.10.027 · Cited by 52
Costa‐Barbosa, F. A., Tonetto‐Fernandes, V. F., Carvalho, V. M., Nakamura, O. H., Moura, V., Bachega, T. A. S. S., Vieira, J. G. H., & Kater, C. E. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03871.x · Cited by 50
Congenital adrenal hyperplasia and acne in male patients
Degitz, K., Placzek, M., Arnold, B., Schmidt, H., & Plewig, G. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05369.x · Cited by 48
Nayak, S., Lee, P. A., & Witchel, S. F. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2715 · Cited by 48
Polycystic ovary syndrome in adolescents: is there an epidemic?
Arslanian, S. A., & Witchel, S. F. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200202000-00006 · Cited by 39
GermlineBRCA1 andHMLH1 mutations in a family with male and female breast carcinoma
Borg, �., Isola, J. J., Chen, J., Rubio‐Terres, C., Johansson, U., Werelius, B., & Lindblom, A. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000315)85:6<796::aid-ijc10>3.0.co;2-l · Cited by 37
The Role Of The Adrenal Cortex In Polycystic Ovary Syndrome
Morán, C., & Azziz, R. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70185-6 · Cited by 45
Congenital adrenal hyperplasia
Dessinioti, C., & Katsambas, A. (2009) · Dermato-Endocrinology · doi:10.4161/derm.1.2.7818 · Cited by 38
Minutolo, C., Nadra, A. D., Fernández, C., Taboas, M., Buzzalino, N., Casali, B., Belli, S., Charreau, E. H., Alba, L., & Dain, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015899 · Cited by 31
Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia
Robins, T., Bellanné‐Chantelot, C., Barbaro, M., Cabrol, S., Wedell, A., & Lajić, S. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0121-x · Cited by 36
Classical and nonclassical 21‐hydroxylase deficiency: a molecular study of Argentine patients
Daín, L., Buzzalino, N. D., Oneto, A., Belli, S., Stivel, M., Pasqualini, T., Minutolo, C., Charreau, E. H., & Alba, L. G. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01419.x · Cited by 34
Disorders of excessive hair growth in the adolescent
Plouffe, L. (2000) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(00)80008-x · Cited by 33
Russian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Roldan, M. B., White, C., & Witchel, S. F. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.126 · Cited by 34
Dolžan, V., Preželj, J., Vidan‐Jeras, B., & Breskvar, K. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410132 · Cited by 27
Kahsar-Miller, M., Azziz, R., Feingold, E., & Witchel, S. F. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01620-4 · Cited by 26
Premature pubarche in Mediterranean girls: high prevalence of heterozygous CYP21 mutation carriers
Paris, F., Tardy, V., Chalançon, A., Picot, M., Morel, Y., & Sultan, C. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903511505 · Cited by 22
Adult Female Acne: Recent Advances in Pathophysiology and Therapeutic Approaches
Amuzescu, A., Tampa, M. Ş., Matei, C., & Georgescu, S. R. (2024) · Cosmetics · doi:10.3390/cosmetics11030074 · Cited by 22
A Rare Duplicated 21-Hydroxylase Haplotype and a de Novo Mutation: A Family Analysis
Baumgartner-Parzer, S. M., Nowotny, P., Waldhäusl, W., & Vierhapper, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021589 · Cited by 17
Ng, J. L., Lim, E. M., Zhang, R., Beilby, J. P., Watts, G. F., Brown, S. J., & Stuckey, B. G. A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad377 · Cited by 15
Bojunga, J., Welsch, C., Antes, I., Albrecht, M., Lengauer, T., & Zeuzem, S. (2005) · Human Genetics · doi:10.1007/s00439-005-1339-3 · Cited by 16
Inter- and intrafamilial variability in premature pubarche and polycystic ovary syndrome
Sanders, E. B., Aston, C. E., Ferrell, R. E., & Witchel, S. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03252-1 · Cited by 17
Witchel, S. F., Trivedi, R. N., & Kammerer, C. M. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00506-5 · Cited by 15
Dörr, H.-G., Schulze, N., Bettendorf, M., Binder, G., Bonfig, W., Denzer, C., Dunstheimer, D., Salzgeber, K., Schmidt, H., Schwab, K. O., et al. (2020) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-020-00100-w · Cited by 14
Molecular defects of the CYP21 gene in Spanish girls with isolated precocious pubarche
Potau, N., Riqué, S., Eduardo, I., Marcos, V., & Ibáñez, L. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470485 · Cited by 16
Mantovani, V., Dondi, E., Larizza, D., Cisternino, M., Bragliani, M., Viggiani, M., Martinetti, M., & Cuccia, M. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200778 · Cited by 14
Witchel, S. F., Fagerli, J., Siegel, J., Smith, R. R., Mitwally, M. F., Lewy, V. D., Arslanian, S. A., & Lee, P. A. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00568-3 · Cited by 13
Silva, R. S., Carvalho, B., Pedro, J. M. P., Castro-Correia, C., Carvalho, D. M., Carvalho, F., & Fontoura, M. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000437 · Cited by 12
Molecular approach to common causes of female infertility
Simpson, J. L. (2002) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2002.0317 · Cited by 12
Endokrinologische Aspekte bei Akne
Degitz, K., Placzek, M., Arnold, B., Schmidt, H., & Plewig, G. (2001) · Fortschritte der praktischen Dermatologie und Venerologie · doi:10.1007/978-3-642-56437-6_25 · Cited by 11
Erdeve, Ş. S., Berberoğlu, M., Yurur-Kutlay, N., Şıklar, Z., Hacıhamdioğlu, B., Tükün, A., & Öçal, G. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.354 · Cited by 10
Genetic factors in common disorders of female infertility
Simpson, J. L. (2000) · Reproductive Medicine Review · doi:10.1017/s0962279900000314 · Cited by 10
Lack of association between CYP21 V281L variant and polycystic ovary syndrome in Italian women
Pucci, L., Lucchesi, D., Longo, V. G., Prato, S. D., & Maffei, S. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003649849 · Cited by 9
Witchel, S. F., Smith, R. L., & Suda-Hartman, M. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:2<172::aid-humu17>3.0.co;2-n · Cited by 9
Prank, K., Schulze, E., Eckert, O., Nattkemper, T. W., Bettendorf, M., Maser‐Gluth, C., B, T. J. S. A., Grote, A., Penner, E., Mühlen, A. V. Z., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01957 · Cited by 8
Genetic Regulation of the Variation in Pubertal Timing
Hodges, C. A., & Palmert, M. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-499-5_4 · Cited by 8
Hirsutismo: diagnóstico diferencial
Marcondes, J. A. M. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000600019 · Cited by 7
Congenital Adrenal Hyperplasia and Acne in the Male Patients
Dessinioti, C., & Katsambas, A. (2014) · Springer eBooks · doi:10.1007/978-3-540-69375-8_31 · Cited by 6
Polat, S., & Arslan, Y. K. (2022) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2021.2021.0184 · Cited by 4
Strategies for Studying Complex Genetic Traits
Nathan, B. M., Hirschhorn, J. N., & Palmert, M. R. (2004) · The Endocrinologist · doi:10.1097/01.ten.0000146242.75018.a9 · Cited by 2
Störungen der Bildung von Sexualsteroidhormonen und Hyperandrogenämie bei der Frau
Wieacker, P. F., & Preisler-Adams, S. (2011) · Medizinische Genetik · doi:10.1007/s11825-011-0276-x · Cited by 1
Pathogenese und Therapie der Akne: Aktuelle Aspekte
Ochsendorf, F. R. (2007) · Aktuelle Dermatologie · doi:10.1055/s-2007-966124 · Cited by 1
Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
Lee, P. A., Fuqua, J. S., & Nebesio, T. D. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/276843 · Cited by 1
Adrenal Glands - The Current Stage and New Perspectives of Diseases and Treatment
Păun, D. L., Cianci, P., & Restini, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102209 · Cited by 1
Congenital Adrenal Hyperplasia – The Main Effect of 21-Hydroxylase Deficiency
Carvalho, B., Carvalho, F., & Carvalho, D. M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.107092 · Cited by 1
Functional and structural studies on CYP21 mutants in congenital adrenal hyperplasia
Robins, T. (2005) · Figshare · Cited by 2
Osinovskaya, N. S., Иващенко, Т. Э., & Баранов, В. С. (2004) · Russian Journal of Genetics · doi:10.1023/b:ruge.0000013452.90203.9f · Cited by 1
Hanstein, B. (2002) · Steinkopff eBooks · doi:10.1007/978-3-642-57533-4_14 · Cited by 1
Janin, C., Vigneron, V., Weryha, G., & Leheup, B. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.10.003
Guazzarotti, L., Blanché, H., Dubbini, L., Bellanné‐Chantelot, C., & BARTOLOTTA, E. (1999) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.1999.1.1.51
Self-citationApplication of Pharmacometrics to Rare Diseases
AHMED, M. A. (2016) · University of Minnesota Digital Conservancy (University of Minnesota)
Dörr, H. G., Schulze, N., Bettendorf, M., Binder, G., Bonfig, W., Denzer, C., Dunstheimer, D., Salzgeber, K., Schmidt, H., Schwab, K. O., et al. (2020) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-020-00976-y
Genetische Aspekte bei Störungen der Fertilität
Wieacker, P. F. (2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-013-1860-9
Polat, S., & Arslan, Y. K. (2021) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2021.0184
von Hagens, C., Heinrich, U., Kiesewetter, F., Rabe, T., Runnebaum, B., Schulze, E., & Vladescú, E. (2001) · Springer eBooks · doi:10.1007/978-3-642-56784-1_5
Polycystic Ovary Syndrome in the Peripubertal Period
Witchel, S. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-499-5_13
Metadata
- Authors
- Blanché, H., Vexiau, P., Clauin, S., Le Gall, I., Fiet, J., Mornet, E., Dausset, J., & Bellanné-Chantelott, C.
- Affiliations
- Fondation Jean Dausset-CEPH (FR)
- Hôpital Saint-Louis (FR)
- ORCID
- Blanché, Hélène
- Venue
- Human Genetics
- Published
- 1997-10
- Volume
- 101
- Issue
- 1
- Pages
- 56-60
- ISSN
- 0018-7348 (ISSN-L)
- 0340-6717
- 1432-1203
- OpenAlex
- W2031439430
- Cited by
- 85
- References
- 25
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 1 · 2016: 1 · 2014: 1 · 2013: 2
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- 21-hydroxylase deficiency, non-classical congenital adrenal hyperplasia, CYP21, hyperandrogenism, 17-hydroxyprogesterone, compound heterozygosity, molecular diagnosis, genetic counseling
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adrenocorticotropic Hormone, Adult, Alleles, Base Sequence, Child, Cortodoxone, Female, Genetic Counseling, Genetic Testing, Genotype, Heterozygote, Hirsutism, Homozygote, Humans, Middle Aged, Mutation, Phenotype, Steroid 21-Hydroxylase, Polymerase Chain Reaction, Hyperandrogenism, DNA Primers, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.